Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year.
The study will be published in the July 3rd issue of the Public Library of Science (PLoS) Computational Biology journal.
The active component in Comtan tablets (entacapone) is effective at inhibiting M.tuberculosis in concentrations well below a level that is toxic to cells.

Link:http://www.newswise.com/articles/view/553799/?sc=rsmn
Source:Newswise